FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2192945332> ?p ?o ?g. }

• W2192945332 endingPage "457" @default.
• W2192945332 startingPage "443" @default.
• W2192945332 abstract "Objectives The aim of this study was to investigate the role of CD133 in pancreatic ductal adenocarcinoma malignancy and its involvement in epidermal growth factor receptor (EGFR) signaling. Methods The effects of CD133 overexpression on cell proliferation, migration, invasiveness, and angiogenesis were investigated in the human pancreatic ductal adenocarcinoma cell line AsPC-1 in vitro and severe combined immunodeficiency xenografts in vivo. Results AsPC-1 cells overexpressing CD133 (AsPC-1 CD133 cells) had elevated cell proliferation, tumorigenesis, cell cycle progression, adhesion, migration, and angiogenesis. AsPC-1 CD133 cells displayed increased survival during treatment with chemotherapeutic agents. CD133 overexpression resulted in decreased EGF expression, increased telomerase reverse transcriptase expression, and increased Akt phosphorylation. Immunoprecipitation assays and immunofluorescent labeling studies revealed that CD133 physically interacts with EGFR. The EGFR inhibitor gefitinib was shown to have potent anti-CD133 activity, decreasing the CD133-induced migration of AsPC-1 CD133 cells. Knockdown of CD133 was also observed to inhibit AsPC-1 CD133 cell proliferation, migration, and invasion. Conclusion Our results indicate that CD133-induced cancer stem cell activity may arise from enhanced telomerase reverse transcriptase expression and CD133 ligand-independent EGFR activation to exhibit the cancer stem cell phenotype, promoting cancer stem cell proliferation independent of cytokines, with high metastatic potential and the development of chemoresistance." @default.
• W2192945332 created "2016-06-24" @default.
• W2192945332 creator A5013430698 @default.
• W2192945332 creator A5013496599 @default.
• W2192945332 creator A5047269467 @default.
• W2192945332 creator A5068209077 @default.
• W2192945332 creator A5072757774 @default.
• W2192945332 creator A5074828105 @default.
• W2192945332 creator A5084240133 @default.
• W2192945332 creator A5087031696 @default.
• W2192945332 date "2016-03-01" @default.
• W2192945332 modified "2023-09-25" @default.
• W2192945332 title "Pancreatic Tumor Progression Associated With CD133 Overexpression" @default.
• W2192945332 cites W1949135884 @default.
• W2192945332 cites W1966087162 @default.
• W2192945332 cites W1976402706 @default.
• W2192945332 cites W1984436335 @default.
• W2192945332 cites W1994070275 @default.
• W2192945332 cites W1994142945 @default.
• W2192945332 cites W1998480886 @default.
• W2192945332 cites W2010653264 @default.
• W2192945332 cites W2013420022 @default.
• W2192945332 cites W2025970479 @default.
• W2192945332 cites W2042015199 @default.
• W2192945332 cites W2045852899 @default.
• W2192945332 cites W2055904567 @default.
• W2192945332 cites W2067243578 @default.
• W2192945332 cites W2075177970 @default.
• W2192945332 cites W2083069189 @default.
• W2192945332 cites W2083479805 @default.
• W2192945332 cites W2084343793 @default.
• W2192945332 cites W2086316954 @default.
• W2192945332 cites W2100801124 @default.
• W2192945332 cites W2115131718 @default.
• W2192945332 cites W2117692326 @default.
• W2192945332 cites W2117735955 @default.
• W2192945332 cites W2124863710 @default.
• W2192945332 cites W2131170195 @default.
• W2192945332 cites W2141002545 @default.
• W2192945332 cites W2143291443 @default.
• W2192945332 cites W2152387543 @default.
• W2192945332 cites W2168557205 @default.
• W2192945332 doi "https://doi.org/10.1097/mpa.0000000000000460" @default.
• W2192945332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26646272" @default.
• W2192945332 hasPublicationYear "2016" @default.
• W2192945332 type Work @default.
• W2192945332 sameAs 2192945332 @default.
• W2192945332 citedByCount "18" @default.
• W2192945332 countsByYear W21929453322016 @default.
• W2192945332 countsByYear W21929453322017 @default.
• W2192945332 countsByYear W21929453322018 @default.
• W2192945332 countsByYear W21929453322019 @default.
• W2192945332 countsByYear W21929453322020 @default.
• W2192945332 countsByYear W21929453322021 @default.
• W2192945332 countsByYear W21929453322022 @default.
• W2192945332 countsByYear W21929453322023 @default.
• W2192945332 crossrefType "journal-article" @default.
• W2192945332 hasAuthorship W2192945332A5013430698 @default.
• W2192945332 hasAuthorship W2192945332A5013496599 @default.
• W2192945332 hasAuthorship W2192945332A5047269467 @default.
• W2192945332 hasAuthorship W2192945332A5068209077 @default.
• W2192945332 hasAuthorship W2192945332A5072757774 @default.
• W2192945332 hasAuthorship W2192945332A5074828105 @default.
• W2192945332 hasAuthorship W2192945332A5084240133 @default.
• W2192945332 hasAuthorship W2192945332A5087031696 @default.
• W2192945332 hasConcept C121608353 @default.
• W2192945332 hasConcept C126322002 @default.
• W2192945332 hasConcept C1491633281 @default.
• W2192945332 hasConcept C2779256057 @default.
• W2192945332 hasConcept C2779438470 @default.
• W2192945332 hasConcept C2780210213 @default.
• W2192945332 hasConcept C2780394083 @default.
• W2192945332 hasConcept C2780932548 @default.
• W2192945332 hasConcept C28328180 @default.
• W2192945332 hasConcept C502942594 @default.
• W2192945332 hasConcept C54355233 @default.
• W2192945332 hasConcept C55427017 @default.
• W2192945332 hasConcept C555283112 @default.
• W2192945332 hasConcept C62112901 @default.
• W2192945332 hasConcept C71924100 @default.
• W2192945332 hasConcept C86803240 @default.
• W2192945332 hasConcept C95444343 @default.
• W2192945332 hasConceptScore W2192945332C121608353 @default.
• W2192945332 hasConceptScore W2192945332C126322002 @default.
• W2192945332 hasConceptScore W2192945332C1491633281 @default.
• W2192945332 hasConceptScore W2192945332C2779256057 @default.
• W2192945332 hasConceptScore W2192945332C2779438470 @default.
• W2192945332 hasConceptScore W2192945332C2780210213 @default.
• W2192945332 hasConceptScore W2192945332C2780394083 @default.
• W2192945332 hasConceptScore W2192945332C2780932548 @default.
• W2192945332 hasConceptScore W2192945332C28328180 @default.
• W2192945332 hasConceptScore W2192945332C502942594 @default.
• W2192945332 hasConceptScore W2192945332C54355233 @default.
• W2192945332 hasConceptScore W2192945332C55427017 @default.
• W2192945332 hasConceptScore W2192945332C555283112 @default.
• W2192945332 hasConceptScore W2192945332C62112901 @default.
• W2192945332 hasConceptScore W2192945332C71924100 @default.
• W2192945332 hasConceptScore W2192945332C86803240 @default.

• next